Our 3-Part Portfolio | Incyte

Hear from Steven Stein, our Executive Vice President and Chief Medical Officer, to learn more about what we do. Our portfolio is divided into 3 pillars: Targeted Therapy, which is targeted toward cancer and genetic pathways; Immuno-oncology, which looks at the hosts themselves (where the cancer is sitting within the human); and Inflammation and Autoimmunity, where we're using our own compounds to see how these can help treat inflammation and autoimmune diseases.

Find Incyte online & on social media: